Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$0.36 - $1.78 $684 - $3,382
1,900 Added 8.88%
23,300 $9,000
Q2 2023

Aug 11, 2023

BUY
$1.22 - $2.13 $1,342 - $2,343
1,100 Added 5.42%
21,400 $38,000
Q1 2023

May 12, 2023

BUY
$1.39 - $2.26 $1,529 - $2,485
1,100 Added 5.73%
20,300 $28,000
Q4 2022

Feb 13, 2023

BUY
$1.32 - $69.2 $792 - $41,520
600 Added 3.23%
19,200 $29,000
Q3 2022

Nov 14, 2022

BUY
$3.18 - $66.0 $1,908 - $39,600
600 Added 3.33%
18,600 $59,000
Q2 2022

Aug 12, 2022

BUY
$2.83 - $4.02 $50,940 - $72,359
18,000 New
18,000 $70,000
Q2 2021

Aug 13, 2021

SELL
$5.13 - $7.63 $378,594 - $563,094
-73,800 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$3.63 - $11.77 $13,746 - $44,572
-3,787 Reduced 4.88%
73,800 $518,000
Q4 2020

Feb 10, 2021

BUY
$3.21 - $5.26 $52,923 - $86,721
16,487 Added 26.98%
77,587 $272,000
Q3 2020

Nov 13, 2020

BUY
$3.85 - $5.5 $63,910 - $91,300
16,600 Added 37.3%
61,100 $259,000
Q2 2020

Aug 13, 2020

SELL
$4.15 - $6.04 $67,773 - $98,639
-16,331 Reduced 26.85%
44,500 $225,000
Q1 2020

May 14, 2020

BUY
$3.07 - $8.26 $186,751 - $502,464
60,831 New
60,831 $274,000
Q4 2019

Feb 13, 2020

SELL
$6.97 - $12.3 $325,457 - $574,336
-46,694 Closed
0 $0
Q3 2019

Nov 13, 2019

SELL
$9.45 - $17.17 $700,122 - $1.27 Million
-74,087 Reduced 61.34%
46,694 $444,000
Q2 2019

Aug 12, 2019

SELL
$12.52 - $20.81 $523,336 - $869,858
-41,800 Reduced 25.71%
120,781 $1.62 Million
Q1 2019

May 14, 2019

BUY
$1.81 - $38.86 $294,271 - $6.32 Million
162,581 New
162,581 $3.32 Million

About BIO-PATH HOLDINGS INC


  • Ticker BPTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,160,160
  • Market Cap $7.3M
  • Description
  • Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the...
More about BPTH
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.